Page last updated: 2024-09-04

carbapenems and aspirin

carbapenems has been researched along with aspirin in 1 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(aspirin)
Trials
(aspirin)
Recent Studies (post-2010) (aspirin)
7,3551475,27748,9476,81713,778

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)aspirin (IC50)
Prostaglandin G/H synthase 1 Bos taurus (cattle)0.35
Integrin beta-3Homo sapiens (human)5
Prostaglandin G/H synthase 1Ovis aries (sheep)0.8252
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)1.375
Integrin alpha-IIbHomo sapiens (human)5
Prostaglandin G/H synthase 1Homo sapiens (human)2.271
Substance-P receptorCavia porcellus (domestic guinea pig)2.4
Prostaglandin G/H synthase 2Homo sapiens (human)2.15
Urotensin-2 receptorRattus norvegicus (Norway rat)0.3
4-aminobutyrate aminotransferase, mitochondrialRattus norvegicus (Norway rat)2.4
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)0.35
Prostaglandin G/H synthase 2Ovis aries (sheep)2.4081

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Andini, R; Boccia, F; Corcione, A; De Rosa, R; Durante-Mangoni, E; Gagliardi, M; Karruli, A; Murino, P; Patauner, F; Ruocco, G; Sommese, P; Ursi, MP; Zampino, R1

Other Studies

1 other study(ies) available for carbapenems and aspirin

ArticleYear
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Microbial drug resistance (Larchmont, N.Y.), 2021, Volume: 27, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carbapenems; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; SARS-CoV-2; Steroids; Survival Analysis; Treatment Outcome

2021